Silo Pharma is pursuing a development plan using its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis. Silo Pharma is pursuing a development plan using its…
During the recent animal study, Silo Pharma tested the disease-suppressive abilities of SPU-21's peptide-guided anti-arthritis properties against ... During the recent animal study, Silo Pharma tested the disease-suppressive abilities of…
SPU-21 effective in controlling arthritis progression. ... liposomal joint homing peptides as a potential therapy for rheumatoid arthritis (RA). SPU-21 effective in controlling arthritis progression. ... liposomal joint homing…
SPU-21 effective in controlling arthritis progression. . You can read further details here. Silo Pharma Inc. had a pretty Dodgy run when it comes ... SPU-21 effective in controlling arthritis…